Top Industry Leaders in the Lancet Market
Latest Lancet Companies Update:
The Lancet and The Financial Times Launch "The Lancet Oncology: Global Oncology" Section: This new section aims to address global disparities in cancer care and promote equitable access to cancer treatment and prevention.
The Lancet and Elsevier Sign Open Access Agreement for "The Lancet Psychiatry": This agreement makes the journal fully open access, providing free access to all published research to readers worldwide.
The Lancet Appoints New Editor-in-Chief: Richard Horton, who previously served as Editor-in-Chief from 1995 to 2021, returns to lead the journal, focusing on strengthening its role in global health advocacy and tackling critical health challenges.
The Lancet Launches "The Lancet Data Platform": This new platform provides researchers with access to a curated collection of open-access health data sets, facilitating research and collaboration.
The Lancet Expands its Global Network of Partner Journals: The Lancet continues to partner with research institutions and medical communities worldwide to establish regional editions of the journal, promoting diversity and local perspectives in healthcare research.
List of Lancet Key companies in the market
- HTL-STREFA S.A. (Poland)
- Terumo Corporation (Japan)
- Becton Dickinson and Company (US)
- Hoffmann-La Roche Ltd. (Switzerland)
- Improve Medical Instruments Co. Ltd. (US)
- Bayer AG (Germany)
- Sarstedt AG & Co. (Germany)
- Abbott Laboratories (US)
- Greiner Bio-One International GmbH (US)